Bladder cancer: Molecular determinants of personalized therapy

JOSE CARLOS REYMUNDO GARCIAANTONIO LOPEZ BELTRAN2026-01-292026-01-29201510.2174/13894501166661502041157562-s2.0-84924292913https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/25932Clinical BiochemistryDrug DiscoveryMolecular MedicinePharmacologyBladder cancer: Molecular determinants of personalized therapyresearch article